We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+12.99%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.44B
AUM Growth
+$256M
(+22%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
7.91%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
441
New
39
Increased
147
Reduced
212
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$77.5M |
| 2 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
+$45.5M |
| 3 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$18.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$5.5M |
| 5 |
DXC Technology
DXC
|
+$3.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$37.6M |
| 2 |
CVS Health
CVS
|
+$4.87M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$4.8M |
| 4 |
SHPG
Shire pic
SHPG
|
+$4.39M |
| 5 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.2% |
| 3 | Financials | 11.69% |
| 4 | Industrials | 8.11% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Check Point Software Technologies
CHKP
$14.3B
| $751K | 0.05% |
5,938
-74
| -1% | -$8.6K |
|
252
Ally Financial
ALLY
$13.1B
| $732K | 0.05% |
26,629
+292
| +1% | +$7.62K |
|
253
Blackstone Mortgage Trust
BXMT
$2.77B
| $729K | 0.05% |
21,085
+373
| +2% | +$12.7K |
|
254
iShares MSCI EAFE ETF
EFA
$76.4B
| $716K | 0.05% |
11,046
+1,920
| +21% | +$121K |
|
255
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
| $713K | 0.05% |
5,537
+203
| +4% | +$25.8K |
|
256
APA Corp
APA
$13B
| $696K | 0.05% |
20,086
+72
| +0.4% | +$2.35K |
|
257
Henry Schein
HSIC
$9.78B
| $685K | 0.05% |
11,392
-2,837
| -20% | -$171K |
|
258
Huntsman Corp
HUN
$2.1B
| $679K | 0.05% |
30,175
-1,981
| -6% | -$44.6K |
|
259
Lam Research
LRCX
$316B
| $666K | 0.05% |
37,220
-220
| -0.6% | -$3.67K |
|
260
Intuitive Surgical
ISRG
$127B
| $656K | 0.05% |
3,450
+51
| +2% | +$9.06K |
|
261
White Mountains Insurance
WTM
$5.33B
| $652K | 0.05% |
705
-32
| -4% | -$29K |
|
|
BNY
262
Bank of New York Mellon
BNY
$103B
| $651K | 0.05% |
12,903
+994
| +8% | +$51.2K |
|
263
NVIDIA
NVDA
$4.6T
| $647K | 0.05% |
144,240
-6,640
| -4% | -$25.8K |
|
264
iShare MSCI Eurozone ETF
EZU
$9.38B
| $646K | 0.05% |
16,730
-783
| -4% | -$29.4K |
|
|
GRFS
265
Grifois
GRFS
$5.55B
| $623K | 0.04% |
30,962
-4,174
| -12% | -$79.8K |
|
266
American Express
AXP
$224B
| $613K | 0.04% |
5,609
+357
| +7% | +$37.5K |
|
267
Bio-Rad Laboratories Class A
BIO
$8.76B
| $612K | 0.04% |
2,003
+12
| +0.6% | +$3.24K |
|
268
ConocoPhillips
COP
$144B
| $612K | 0.04% |
9,170
+432
| +5% | +$29.1K |
|
269
State Street SPDR S&P International Small Cap ETF
GWX
$839M
| $612K | 0.04% |
20,199
| – | – |
|
270
AerCap
AER
$23.4B
| $600K | 0.04% |
12,886
-477
| -4% | -$21.5K |
|
271
United Therapeutics
UTHR
$26.1B
| $598K | 0.04% |
5,093
-50
| -1% | -$5.83K |
|
|
AMJ
272
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $597K | 0.04% |
23,408
-1,505,130
| -98% | -$37.6M |
|
273
GE Aerospace
GE
$364B
| $596K | 0.04% |
11,976
-936
| -7% | -$44.1K |
|
274
Lamb Weston
LW
$7.42B
| $596K | 0.04% |
7,951
-73
| -0.9% | -$5.17K |
|
275
Kroger
KR
$36.7B
| $592K | 0.04% |
24,059
+13,540
| +129% | +$371K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q1 2019 Portfolio in Review
As of Q1 2019, RegentAtlantic Capital held 441 positions worth $1.44B, up 22% from $1.18B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
RegentAtlantic Capital deployed $114M of net new capital in Q1 2019, opening 39 new positions and adding to 147 existing holdings. Its largest new stake was Takeda Pharmaceutical: 82,523 shares worth $1.68M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $37.6M trimmed.
- RegentAtlantic Capital's largest Q1 2019 buy was Takeda Pharmaceutical: 82,523 shares worth $1.68M.
- RegentAtlantic Capital added most to iShares Core MSCI Emerging Markets ETF in Q1 2019, an estimated $77.5M increase.
- RegentAtlantic Capital's biggest Q1 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $37.6M.
- RegentAtlantic Capital fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $4.8M.
- RegentAtlantic Capital's ten largest holdings make up 26% of its $1.44B portfolio in Q1 2019.
- RegentAtlantic Capital opened 39 new positions and closed 8 in Q1 2019.
- RegentAtlantic Capital's portfolio value rose 22% quarter-over-quarter to $1.44B.
Based on RegentAtlantic Capital's 13F filing for Q1 2019, filed 3 May 2019.